MedPath

PHARMABIOTIX, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

The Efficacy of PX0612 In The Treatment Of Irritable Bowel Syndrome

Not Applicable
Completed
Conditions
Irritable Bowel Syndrome With Diarrhea
Interventions
Dietary Supplement: PX0612
Dietary Supplement: Di-Calcium Phosphate
First Posted Date
2015-05-01
Last Posted Date
2020-06-12
Lead Sponsor
Pharmabiotix Inc
Target Recruit Count
50
Registration Number
NCT02431533
Locations
🇨🇦

University of Alberta Hospital, Edmonton, Alberta, Canada

© Copyright 2025. All Rights Reserved by MedPath